ArriVent BioPharma (AVBP) Insider Trading & Ownership → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free AVBP Stock Alerts $15.44 -0.10 (-0.64%) (As of 04/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media ArriVent BioPharma (NASDAQ:AVBP) Insider Buying and Selling ActivityNumber OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$18.00 MNumber OfInsiders Selling(Last 12 Months)0 Get AVBP Insider Trade Alerts Want to know when executives and insiders are buying or selling ArriVent BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVBP Insider Buying and Selling by Quarter Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 ArriVent BioPharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/30/2024Hillhouse Investment ManagemenMajor ShareholderBuy555,555$18.00$9,999,990.00 1/30/2024Orbimed Advisors LlcDirectorBuy444,444$18.00$7,999,992.00 (Data available from 1/1/2013 forward) AVBP Insider Trading Activity - Frequently Asked Questions Who is on ArriVent BioPharma's Insider Roster? The list of insiders at ArriVent BioPharma includes Hillhouse Investment Managemen, and Orbimed Advisors Llc. Learn more on insiders at AVBP. Which ArriVent BioPharma insiders have been buying company stock? The following insiders have purchased AVBP shares in the last 24 months: Hillhouse Investment Managemen ($9,999,990.00), and Orbimed Advisors Llc ($7,999,992.00). How much insider buying is happening at ArriVent BioPharma? Insiders have purchased a total of 999,999 AVBP shares in the last 24 months for a total of $17,999,982.00 bought. More Insider Trading Tools from MarketBeat Related Companies: Korro Bio Insider Trading Stoke Therapeutics Insider Trading Mineralys Therapeutics Insider Trading AnaptysBio Insider Trading Phibro Animal Health Insider Trading COMPASS Pathways Insider Trading Olema Pharmaceuticals Insider Trading Phathom Pharmaceuticals Insider Trading Verve Therapeutics Insider Trading Nuvation Bio Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:AVBP) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
